Skip to main content

Table 2 Demographic data of individuals tested for Trypanosoma cruzi infection in Germany and the years 2000–2018

From: Describing nearly two decades of Chagas disease in Germany and the lessons learned: a retrospective study on screening, detection, diagnosis, and treatment of Trypanosoma cruzi infection from 2000 – 2018

Sex

Female

n = 2389/5991

39.9%

Male

n = 2365/5991

39.5%

Unknown

n = 1237/5991

20.6%

All

n = 5991

100.0%

Age at time of testing

Data on age available on 2312/2389 (96.8%)

n = 2312

Data on age available on 2322/2365 (98.2%)

n = 2322

Data on age available on

277/1237 (22.4%)

n = 277

Data on age available on 4911/5991 (82.0%)

n = 4911

 Mean (SD)

37.4 years (SD = 16.0)

41.2 years (SD = 16.6)

35.4 years (SD = 21.3)

39.1 years (SD = 16.7)

 ≤14

78 (3.4%)

87 (3.7%)

67 (24.2%)

232 (4·7%)

 15–49

1695 (73.3%)

1474 (63.5%)

146 (52.7%)

3315 (67.5%)

 ≥50

539 (23.3%)

761 (32.8%)

64 (23.1%)

1364 (27.8%)

Nationality

Data on nationality available on

417/2389 (17.5%) n = 417

Data on nationality available on

378/2365 (16.0%) n = 378

Data on nationality available on

19/1237 (1.5%) n = 19

Data on nationality available on

814/5991 (13.6%) n = 814

 Argentina

7 (1.7%)

0

0

7 (0.9%)

 Bolivia

18 (4.3%)

13 (3.4%)

0

31 (3.8%)

 Brazil

24 (5.8%)

9 (2.4%)

3 (15.8%)

36 (4.4%)

 Colombia

11 (2.6%)

2 (0.5%)

0

13 (1.6%)

 Costa Rica

1 (0.2%)

0

0

1 (0.1%)

 Ecuador

4 (1.0%)

4 (1.1%)

0

8 (1.0%)

 El Salvador

1 (0.2%)

0

0

1 (0.1%)

 Guatemala

1 (0.2%)

0

0

1 (0.1%)

 Mexico

5 (1.2%)

0

0

5 (0.6%)

 Nicaragua

1 (0.2%)

0

0

1 (0.1%)

 Panama

0

1 (0.3%)

0

1 (0.1%)

 Paraguay

5 (1.2%)

2 (0.5%)

0

7 (0.9%)

 Peru

6 (1.4%)

6 (1.6%)

0

12 (1.5%)

 Venezuela

4 (1.0%)

1 (0.3%)

1 (5.3%)

6 (0.7%)

 Germany

297 (71.2%)

318 (84.1%)

12 (63.2%)

627 (77.0%)

 Other non-endemic countries

32 (7.7%)

22 (5.8%)

3 (15.8%)

57 (7.0%)

  1. SD Standard deviation